Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AdvisorShares Psychedelics ETF (NY:PSIL)

18.80 -0.14 (-0.77%)
Streaming Delayed Price Updated: 9:44 AM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,712
Open 18.62
Bid (Size) 18.77 (300)
Ask (Size) 18.91 (300)
Prev. Close 18.94
Today's Range 18.62 - 19.06
52wk Range 9.580 - 21.61
Shares Outstanding 7,499
Dividend Yield 0.43%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug
Quantum Biopharma's subsidiary, Huge Biopharma Australia, has cleared a regulatory milestone for its neuroprotective compound, Lucid-MS, in a Phase 1 trial. 
Via Benzinga
Compass Pathways Stock Slumps After Positive Late-Stage Trial Results From Psychedelic Drug ‘Underwhelm’ Analysts
The company said it will discuss the “highly statistically significant and clinically meaningful” data with the U.S. Food and Drug Administration, which has yet to review it. 
Via Stocktwits

Performance

YTD
+55.1%
+55.1%
1 Month
-6.6%
-6.6%
3 Month
+11.6%
+11.6%
6 Month
+60.3%
+60.3%
1 Year
+56.8%
+56.8%

More News

Read More
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors
Via Benzinga
Topics Government
5 ETFs That Beat Market Turmoil With Gains Last Week
Via Benzinga
Topics ETFs Economy
High-Momentum ETFs Leading the Market This Year
Via MarketBeat
Topics ETFs
Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding
Via Stocktwits
Mind Medicine Stock Rises As Evercore Projects 200% Upside On LSD Formulation: Retail Turns Bullish
Via Stocktwits
5 Best-Performing Sector ETFs Of Q4
Via Talk Markets
Topics ETFs
Why Is Penny Stock Clearmind Gaining Today?
Via Benzinga
5 Best-Performing Sector ETFs Midway In Q4
Via Talk Markets
Topics ETFs
Top And Flop ETFs Of The First Half
Via Talk Markets
Topics ETFs
Best And Worst ETF Zones Of Q2
Via Talk Markets
Topics Artificial Intelligence ETFs Economy
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
Via Benzinga
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Via Benzinga
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Via Benzinga
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Via Benzinga
Topics Economy
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Via Benzinga
Mental Health Mavericks: 3 Stocks Changing the Game
Via InvestorPlace
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
Via Benzinga
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
Via Benzinga
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
Via Benzinga
Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More
Via Benzinga
Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
Via Benzinga
Psychedelic Drug Stocks Index Up In December; Down YTD
Via Talk Markets
Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More
Via Benzinga

Frequently Asked Questions

Is AdvisorShares Psychedelics ETF publicly traded?
Yes, AdvisorShares Psychedelics ETF is publicly traded.
What exchange does AdvisorShares Psychedelics ETF trade on?
AdvisorShares Psychedelics ETF trades on the New York Stock Exchange
What is the ticker symbol for AdvisorShares Psychedelics ETF?
The ticker symbol for AdvisorShares Psychedelics ETF is PSIL on the New York Stock Exchange
What is the current price of AdvisorShares Psychedelics ETF?
The current price of AdvisorShares Psychedelics ETF is 18.80
When was AdvisorShares Psychedelics ETF last traded?
The last trade of AdvisorShares Psychedelics ETF was at 11/04/25 09:44 AM ET
What is the market capitalization of AdvisorShares Psychedelics ETF?
The market capitalization of AdvisorShares Psychedelics ETF is 140.94K
How many shares of AdvisorShares Psychedelics ETF are outstanding?
AdvisorShares Psychedelics ETF has 141K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.